{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:23:56Z","timestamp":1793057036464,"version":"4.5.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Nature Science Foundation of China","award":["81960350"],"award-info":[{"award-number":["81960350"]}]},{"name":"Yunnan Applied Basic Research Project-Union Foundation of China","award":["202201AY070001-091"],"award-info":[{"award-number":["202201AY070001-091"]}]},{"name":"Yunnan Applied Basic Research Project-Union Foundation of China","award":["202001AY070001-258"],"award-info":[{"award-number":["202001AY070001-258"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,18]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Systemic amyloidosis refers to a spectrum of diseases characterized by extracellular deposition of amyloids, with commonrenal involvement; however, simultaneous involvement of cardiac amyloidosis remains rare. The purpose of this report was to enhance the understanding of the diagnosis and treatment of light chain (AL)-type renal amyloidosis with cardiovascular involvement, reduce misdiagnosis and missed diagnosis, and enable timely and effective treatment for such patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 74-year-old male patient was admitted to our hospital because of recurrent edema for over 1 year and aggravated recurrence with decreased urine for 1 month. Pathological examination of the renal biopsy specimen showed homogeneous nonstructural material deposition in the glomerular mesangial area.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>This patient was diagnosed with lightchain (AL)-type renal amyloidosis with cardiac involvement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Treatment with daretomumab (DARA) 800mg plus cyclophosphamide 0.4g, bortezomib 1.6mg and dexamethasone 20mg (D-VCD regimen). Interventions, such as intermittent diuresis, anticoagulation, and electrolyte imbalance, were administered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After 2 courses of chemotherapy, edema was relieved, urine protein was reduced, and symptoms improved. Chemotherapy was continued in accordance with the regimen described above.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Due to the rarity and nonspecific symptoms, missed diagnosis and misdiagnosis of AL-type renal amyloidosis remain common. Among patients with a confirmed diagnosis, in addition to considering the pathological changes in the kidney, consideration of the presence of amyloidosis in other organs, such as cardiac involvement, is also necessary.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000042161","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:01:20Z","timestamp":1746529280000},"page":"e42161","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["AL type renal amyloidosis with cardiac involvement: A case report and literature review"],"prefix":"10.1097","volume":"104","author":[{"given":"Yang","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Nephrology, Sixth Affiliated Hospital of Kunming Medical University, Yuxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sixth Affiliated Hospital of Kunming Medical University, Yuxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong-fen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dali Bai Autonomous Prefecture People\u2019s Hospital, Dali, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-lan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Dali Bai Autonomous Prefecture People\u2019s Hospital, Dali, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-juan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dali Bai Autonomous Prefecture People\u2019s Hospital, Dali, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Emergency, Dali Bai Autonomous Prefecture People\u2019s Hospital, Dali, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3728-2350","authenticated-orcid":false,"given":"Ming-wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Emergency, Dali Bai Autonomous Prefecture People\u2019s Hospital, Dali, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250904","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000508022","article-title":"Confirming the diagnosis of amyloidosis.","volume":"143","author":"Wisniowski","year":"2020","journal-title":"Acta Haematol"},{"key":"R2-20250904","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (Light-Chain) cardiac amyloidosis: a review of diagnosis and therapy.","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250904","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mus.28026","article-title":"Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: recommendations from a panel of experts.","volume":"69","author":"Karam","year":"2024","journal-title":"Muscle Nerve"},{"key":"R4-20250904","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1007\/s12325-022-02139-9","article-title":"Clinical and genetic evaluation of people with or at risk of hereditary ATTR amyloidosis: an expert opinion and consensus on best practice in Ireland and the UK.","volume":"39","author":"Gillmore","year":"2022","journal-title":"Adv Ther"},{"key":"R5-20250904","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000444287","article-title":"The clinical presentation and management of systemic light-chain amyloidosis in China.","volume":"2","author":"Huang","year":"2016","journal-title":"Kidney Dis (Basel)"},{"key":"R6-20250904","doi-asserted-by":"crossref","first-page":"151343","DOI":"10.1016\/j.semnephrol.2023.151343","article-title":"Amyloidosis and the kidney: an update.","volume":"42","author":"Nader","year":"2022","journal-title":"Semin Nephrol"},{"key":"R7-20250904","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clml.2015.11.001","article-title":"Clinical characteristics and treatment outcome of Chinese patients with systemic amyloid light-chain amyloidosis: a retrospective single-center analysis.","volume":"16","author":"Zhao","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R8-20250904","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: a real-world study using US claims data.","volume":"2","author":"Quock","year":"2018","journal-title":"Blood Adv"},{"key":"R9-20250904","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0025-6196(12)65706-1","article-title":"Primary systemic amyloidosis \u2013 a diagnostic primer.","volume":"64","author":"Gertz","year":"1989","journal-title":"Mayo Clin Proc"},{"key":"R10-20250904","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MAJ.0b013e31824e0ec5","article-title":"Immunofixation electrophoresis was highly specific for the diagnosis of renal light-chain amyloidosis.","volume":"345","author":"Zhou","year":"2013","journal-title":"Am J Med Sci"},{"key":"R11-20250904","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/ndt\/gfs501","article-title":"A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis.","volume":"28","author":"Yao","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R12-20250904","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2012-12-473066","article-title":"A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis.","volume":"121","author":"Wechalekar","year":"2013","journal-title":"Blood"},{"key":"R13-20250904","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/01913123.2020.1844355","article-title":"Renal amyloidosis with emphasis on the diagnostic role of electron microscopy.","volume":"44","author":"Herrera","year":"2020","journal-title":"Ultrastruct Pathol"},{"key":"R14-20250904","first-page":"159","article-title":"Amyloidosis-the diagnosis and treatment of an underdiagnosed disease.","volume":"117","author":"Ihne","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"R15-20250904","doi-asserted-by":"crossref","first-page":"e582","DOI":"10.1002\/ctm2.582","article-title":"T cell landscape and dynamics in immunoglobulin light chain amyloidosis before and after daratumumab-based therapy.","volume":"11","author":"Wang","year":"2021","journal-title":"Clin Transl Med"},{"key":"R16-20250904","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12935-022-02635-6","article-title":"Efficacy and safety of intravenous daratumumab-based treatments for AL amyloidosis: a systematic review and meta-analysis.","volume":"22","author":"Sun","year":"2022","journal-title":"Cancer Cell Int"},{"key":"R17-20250904","doi-asserted-by":"crossref","first-page":"100953","DOI":"10.1016\/j.currproblcancer.2023.100953","article-title":"Daratumumab plus bortezomib and dexamethasone in newly diagnosed systemic light chain amyloidosis.","volume":"47","author":"Kennedy","year":"2023","journal-title":"Curr Probl Cancer"},{"key":"R18-20250904","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis.","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"key":"R19-20250904","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/bjh.18733","article-title":"First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapy.","volume":"201","author":"Chakraborty","year":"2023","journal-title":"Br J Haematol"},{"key":"R20-20250904","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1182\/blood.2021014613","article-title":"Daratumumab in AL amyloidosis.","volume":"140","author":"Wechalekar","year":"2022","journal-title":"Blood"},{"key":"R21-20250904","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11523-022-00945-3","article-title":"Selinexor-bortezomib-dexamethasone: a review in previously treated multiple myeloma.","volume":"18","author":"Syed","year":"2023","journal-title":"Target Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T12:01:26Z","timestamp":1756987286000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":21,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042161","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}